Circulating tumour necrosis factor a and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis

被引:57
作者
Klimiuk, PA
Sierakowski, S
Latosiewicz, R
Cylwik, JP
Cylwik, B
Skowronski, J
Chwiecko, J
机构
[1] Med Univ Bialystok, Dept Rheumatol & Internal Dis, PL-15276 Bialystok, Poland
[2] Med Univ Bialystok, Dept Orthopaed Surg, Bialystok, Poland
[3] Med Univ Bialystok, Dept Clin Pathomorphol, Bialystok, Poland
关键词
D O I
10.1136/ard.62.5.472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine the relation between the serum levels of tumour necrosis factor alpha (TNF alpha), soluble tumour necrosis factor receptors (sTNF-R), and the histological pattern of rheumatoid synovitis. Methods: An enzyme linked immunosorbent assay (ELISA) was used to measure TNFalpha, p55 sTNF-R, and p75 sTNF-R concentrations in the serum of 43 patients with rheumatoid arthritis (RA) and 34 patients with osteoarthritis (OA). Results: Upon histological analysis two variants of rheumatoid synovitis emerged. Twenty six RA specimens presented only diffuse infiltrates of mononuclear cells. In the remaining 17 samples the formation of lymphocytic follicles with germinal centre-like structures was found. Serum concentrations of TNFalpha, p55 and p75 sTNF-R were raised in patients with RA compared with the OA control group (p<0.001 for all comparisons). Levels of TNFα, p55 and p75 sTNF-R were higher in the serum of patients with RA with follicular synovitis than in patients with diffuse synovitis (p<0.001, p<0.01, and p<0.05, respectively). Serum concentrations of TNFalpha, p55 and p75 sTNF-R correlated with markers of disease activity. Conclusion: Different histological types of rheumatoid synovitis associated with distinct serum levels of TNFalpha and sTNF-R reflect varying clinical activity of the disease and support the concept of RA heterogeneity.
引用
收藏
页码:472 / 475
页数:4
相关论文
共 15 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]  
COPE AP, 1995, J RHEUMATOL, V22, P382
[3]  
Firestein GS, 1997, TXB RHEUMATOLOGY, P851
[4]  
Klimiuk PA, 1997, AM J PATHOL, V151, P1311
[5]   Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis [J].
Klimiuk, PA ;
Sierakowski, S ;
Latosiewicz, R ;
Cylwik, B ;
Skowronski, J ;
Chwiecko, J .
RHEUMATOLOGY, 2002, 41 (01) :78-87
[6]  
Klimiuk PA, 2001, J RHEUMATOL, V28, P1211
[7]   LEVELS OF CIRCULATING TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RELATIONSHIP TO SERUM LEVELS OF HYALURONAN AND ANTIGENIC KERATAN SULFATE [J].
MANICOURT, DH ;
TRIKI, R ;
FUKUDA, K ;
DEVOGELAER, JP ;
DEDEUXCHAISNES, CN ;
THONAR, EJMA .
ARTHRITIS AND RHEUMATISM, 1993, 36 (04) :490-499
[8]  
RITCHIE DM, 1968, Q J MED, V37, P393
[9]   SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN HUMAN INFLAMMATORY SYNOVIAL-FLUIDS [J].
ROUXLOMBARD, P ;
PUNZI, L ;
HASLER, F ;
BAS, S ;
TODESCO, S ;
GALLATI, H ;
GUERNE, PA ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1993, 36 (04) :485-489
[10]   THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITIS [J].
STEINBROCKER, O ;
TRAEGER, CH ;
BATTERMAN, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1949, 140 (08) :659-662